12.07.2015 Views

Annual Report 10-11 - Elder Pharmaceuticals Ltd.

Annual Report 10-11 - Elder Pharmaceuticals Ltd.

Annual Report 10-11 - Elder Pharmaceuticals Ltd.

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

28 th <strong>Annual</strong> <strong>Report</strong>20<strong>10</strong> - <strong>11</strong>Company OverviewBoard and Management <strong>Report</strong>sFinancial StatementsLifestyle Disease care portfolioProductsMarket opportunitiesto unhealthy lifestyles and increasing stress levels which means there is stillSomazina is ranked secondin the market in theNeuroprotective categoryAPI<strong>Elder</strong> manufactures API and formulations across six manufacturing plants inIndia, possessing a capability to manufacture various dosage forms like tablets,strengthen our position as a supplier of APIs and intermediates in theMarket opportunities19

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!